APA
Westdorp H., Creemers J. H. A., van Oort I. M., Schreibelt G., Gorris M. A. J., Mehra N., Simons M., de Goede A. L., van Rossum M. M., Croockewit A. J., Figdor C. G., Witjes J. A., Aarntzen E. H. J. G., Mus R. D. M., Brüning M., Petry K., Gotthardt M., Barentsz J. O., de Vries I. J. M. & Gerritsen W. R. (20200702). Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer. : Journal for immunotherapy of cancer.
Chicago
Westdorp Harm, Creemers Jeroen H A, van Oort Inge M, Schreibelt Gerty, Gorris Mark A J, Mehra Niven, Simons Michiel, de Goede Anna L, van Rossum Michelle M, Croockewit Alexandra J, Figdor Carl G, Witjes J Alfred, Aarntzen Erik H J G, Mus Roel D M, Brüning Mareke, Petry Katja, Gotthardt Martin, Barentsz Jelle O, de Vries I Jolanda M and Gerritsen Winald R. 20200702. Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer. : Journal for immunotherapy of cancer.
Harvard
Westdorp H., Creemers J. H. A., van Oort I. M., Schreibelt G., Gorris M. A. J., Mehra N., Simons M., de Goede A. L., van Rossum M. M., Croockewit A. J., Figdor C. G., Witjes J. A., Aarntzen E. H. J. G., Mus R. D. M., Brüning M., Petry K., Gotthardt M., Barentsz J. O., de Vries I. J. M. and Gerritsen W. R. (20200702). Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer. : Journal for immunotherapy of cancer.
MLA
Westdorp Harm, Creemers Jeroen H A, van Oort Inge M, Schreibelt Gerty, Gorris Mark A J, Mehra Niven, Simons Michiel, de Goede Anna L, van Rossum Michelle M, Croockewit Alexandra J, Figdor Carl G, Witjes J Alfred, Aarntzen Erik H J G, Mus Roel D M, Brüning Mareke, Petry Katja, Gotthardt Martin, Barentsz Jelle O, de Vries I Jolanda M and Gerritsen Winald R. Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer. : Journal for immunotherapy of cancer. 20200702.